Trial Profile
An Investigator Initiated, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy of Humira (Adalimumab) For The Treatment of Interstitial Cystitis(IC).
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 20 Jul 2015
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Interstitial cystitis
- Focus Registrational; Therapeutic Use
- 25 Aug 2013 Status changed from active, no longer recruiting to completed.
- 20 Jun 2013 Results published in the Journal of Urology.
- 11 Jan 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.